Pearl-type posterior capsule opacification as a possible predisposing factor for malignant glaucoma: a case report

珍珠状后囊膜混浊可能是恶性青光眼的诱发因素:病例报告

阅读:1

Abstract

BACKGROUND: Malignant glaucoma (MG) is associated with a narrow angle or pseudoexfoliation (PEX)-induced laxity of the zonule. We describe a patient with massive posterior capsule opacification (PCO), i.e. Elschnig's Pearls (EP) and Soemmering's ring (SR) causing aqueous misdirection syndrome. CASE PRESENTATION: A 78-year-old female was referred with rapidly progressive left ocular pain, redness, blurred vision of 20/100, and intraocular pressure (IOP) of 60 mmHg. She had undergone cataract surgery 5 years prior without complications, with a preoperative diagnosis of moderate capsular PEX syndrome. She was first treated by intravenous 250 mg acetazolamide along with maximal pressure-lowering drops, 1% pilocarpine and a patent laser iridotomy. Despite adding 500 cc of 10% mannitol, IOP remained high for 3 days. A shallow anterior chamber with angle closure, myopic shift and filling of the posterior chamber by massive PCO led us to conclude an aqueous misdirection syndrome. We promptly switched 1% pilocarpine to 1% atropine and performed a laser iridotomy enlargement with a posterior capsulotomy and anterior hyaloidotomy. This rapidly controlled the condition with posterior displacement of the intraocular lens (IOL) and fading of the high-IOP associated symptoms. CONCLUSIONS: Identifying malignant glaucoma could be challenging in the absence of immediate surgical circumstances. To our knowledge, this is the second description of PCO associated with MG. In this case, PCO was thought to narrow the iridocorneal angle and to cause a relative pupillary blockage, subsequently triggering aqueous humor misdirection to the vitreous and forward displacement of the iris-IOL diaphragm in the context of moderate PEX-induced zonular laxity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。